Our finding that high doses of HSA/TIMP-2 protein inhibit angiogenesis and subsequently inhibit tumor growth is consistent with the findings of previous TIMP-2 studies [10], [11], [16], [54]. The gene discussed is TIMP2; the disease is neoplasm.